March 23, 2026

Amgen Inc. (AMGN) Stock Analysis: Evaluating Growth Potential with a 106.10% ROE

Amgen Inc. (NASDAQ: AMGN) stands as a beacon in the healthcare sector, particularly within the drug manufacturing industry. With a robust market capitalization of $187.49 billion,..

Agilent Technologies, Inc. (A) Stock Analysis: A 46.72% Potential Upside Beckons Investors

Agilent Technologies, Inc. (NYSE: A), a heavyweight in the healthcare sector, particularly within the diagnostics and research industry, stands out with a market capitalization of $31.48..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring an 81% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may find iRhythm Holdings, Inc. (NASDAQ: IRTC) an intriguing prospect, especially given its substantial potential upside of 81.46%...

Haleon plc (HLN) Stock Analysis: Exploring a 20% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, commands the attention of investors with its robust market capitalization of $44.83 billion. Specializing in consumer..

Doximity, Inc. (DOCS) Stock Analysis: Unpacking a Potential 62% Upside

For investors seeking opportunities in the healthcare sector, Doximity, Inc. (NYSE: DOCS) presents an intriguing proposition. As a leader in health information services, Doximity offers a..

RadNet, Inc. (RDNT) Stock Analysis: A 50% Potential Upside with a Strong Buy Consensus

RadNet, Inc. (NASDAQ: RDNT) is capturing investors’ attention with a compelling growth trajectory and an impressive 50.23% potential upside according to current analyst ratings. This Los..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 99% Upside in the Biotechnology Sector

Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company, is garnering investor attention within the biotechnology sector with its promising pipeline of vaccine candidates. Based in San..

Biogen Inc. (BIIB) Stock Analysis: Evaluating a 13.47% Potential Upside Amidst Market Challenges

Biogen Inc. (BIIB), a stalwart in the healthcare sector, continues to captivate investor interest with its extensive portfolio of therapies and a notable potential upside of..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating a 52-Week Highs and Lows for Future Growth

Investors with an eye on the healthcare sector might find Molina Healthcare Inc (NYSE: MOH) an intriguing opportunity. As a key player in the healthcare plans..

Genmab A/S (GMAB) Stock Analysis: Evaluating a 50% Potential Upside in Biotechnology

Genmab A/S (GMAB), a leader in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline and robust analyst ratings. With a..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 27% Upside Potential in Healthcare’s OTC Market

Prestige Consumer Healthcare Inc. (PBH), a key player in the over-the-counter (OTC) healthcare products market, presents a compelling investment opportunity for those looking to capitalize on..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 20% Upside Potential

Roivant Sciences Ltd. (ROIV), a biopharmaceutical company based in London, is capturing investor attention in the biotechnology sector with its promising pipeline and a notable market..

ICON plc (ICLR) Stock Analysis: Exploring a 39% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a leading player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking exposure to the..

Madrigal Pharmaceuticals, Inc. (MDGL) Investor Outlook: Examining the 51.55% Potential Upside

Madrigal Pharmaceuticals, Inc. (MDGL), a key player in the biotechnology sector, is making waves with its focus on developing therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). Headquartered..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Poised for 23.74% Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (JAZZ), a global player in the biotechnology sector, is capturing investor attention with a robust potential upside of 23.74% based on current analyst..

Alkermes plc (ALKS) Investor Outlook: Evaluating a 55% Upside Potential with Solid Buy Ratings

Alkermes plc (NASDAQ: ALKS), headquartered in Dublin, Ireland, operates in the competitive healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market..

Legend Biotech Corporation (LEGN) Stock Analysis: A 233% Potential Upside Amidst Robust Revenue Growth

Legend Biotech Corporation (NASDAQ: LEGN) is a burgeoning player in the biotechnology sector, focusing on innovative cell therapies aimed at treating various forms of cancer. The..

UnitedHealth Group (UNH) Stock Analysis: A Look at 31% Potential Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable entity in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $250.15..

ADMA Biologics Inc (ADMA): Investor Outlook on a Biotech Firm with 79% Upside Potential

ADMA Biologics Inc (NASDAQ: ADMA) presents a compelling opportunity for investors with a keen interest in the healthcare sector, particularly within the biotechnology industry. Based in..

Insmed Incorporated (INSM) Stock Analysis: A Promising Biotech with 56.62% Potential Upside

For investors in the biotechnology sector, Insmed Incorporated (NASDAQ: INSM) represents a compelling opportunity, driven by its robust pipeline and significant potential upside of 56.62% based..

Search

Funds

March 23, 2026

Search

Funds

March 23, 2026

FTSE 100

Funds